Showing 1 - 20 results of 145,567 for search '(( 5 nm decrease ) OR ((( 5 cm decrease ) OR ( a ((point decrease) OR (_ decrease)) ))))', query time: 0.82s Refine Results
  1. 1
  2. 2

    Variable importance plot (mean decrease accuracy and mean decrease Gini). by Fernando Martinez-Taboada (8655132)

    Published 2020
    “…The variables are presented from descending importance. The mean decrease in Gini coefficient is a measure of how each variable contributes to the homogeneity of the nodes and leaves in the resulting random forest. …”
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Delphinidin alters VEGF-A splicing to increase VEGF-A<sub>165</sub>b and decrease total VEGF-A expression. by Megan Stevens (3964886)

    Published 2019
    “…<p><b>A)</b> Treatment of podocytes with delphinidin chloride (10 μg/ml) under normal glucose (NG; 5 mM glucose + 25 mM mannitol) and high glucose (HG; 30 mM glucose, 1 ng/ml TNFα, 1 ng/ml IL-6, and 100 nM insulin) for 48 hrs increased the protein expression of VEGF-A<sub>165</sub>b relative to total VEGF-A<sub>165</sub> (quantified in <b>B</b>; *p<0.05 vs NG, †p<0.05 vs HG; n = 3 biological repeats; One-way ANOVA with Bonferroni post-hoc test for comparison between pairs; <b>A</b>—the same blot was first probed with VEGF-A<sub>165</sub>b before stripping and reprobing with panVEGF-A). …”
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Behavior of split<sup><50cM</sup> <i>ClvR</i> V2 with linkage. by Georg Oberhofer (3401438)

    Published 2021
    “…<p>Incorporating linkage into split <i>ClvR</i> (split<sup><50cM</sup> <i>ClvR</i> V2) results in a graded increase in drive strength, and duration of <i>Rescue</i>/Cargo/gRNAs at high frequency, as the degree of linkage increases (map distance decreases). …”
  15. 15
  16. 16

    Example of K<sup>trans</sup> decrease during therapy. by Jean-Philip Daniel Weber (12213395)

    Published 2022
    “…<p>NSCLC of the left upper lobe showing a clear decrease of K<sup>trans</sup> from baseline (left) to first follow-up after 1 week of checkpoint inhibition by Erlotinib and Bevacizumab.…”
  17. 17
  18. 18
  19. 19
  20. 20